In this allo-HSCT model IL-22 producing ILC3 enhanced intestinal stem cell functions, and IL-22 deficiency resulted in increased incidence and severity of GvHD with excessive epithelial cell apoptosis and disrupted intestinal mucosal barrier (67). This evidence concerns the gene IL22 and graft versus host disease.